Cardiac magnetic resonance imaging vs invasive coronary angiography as primary strategy in heart failure with reduced ejection fraction - A diagnostic randomized trial

2 September 2024 (09:33 - 09:45)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Doctor Guelmisal Gueder

University Hospital Wuerzburg, Wuerzburg (Germany)

7 More presentations in this session

Presentation thumbnail

Extracorporeal life support for acute myocardial infarction complicated by cardiogenic shock - 12 months results of the ECLS-SHOCK trial

Professor S. Desch (Leipzig, DE)

Presentation thumbnail

Impact of baseline surgical risk on the treatment effect of PCI and CABG in ischemic left ventricular systolic dysfunction: results of the REVIVED-BCIS2 and STICH randomized controlled trials

Doctor G. Marquis-Gravel (Montreal, CA)

Presentation thumbnail

Empagliflozin for prevention of acute kidney injury in patients with type 2 diabetes mellitus undergoing extracorporeal on-pump CABG: The POST-CABGDM trial

Doctor F. Pitta (Sao Paulo, BR)

Presentation thumbnail

Comparative Effectiveness of Percutaneous and Surgical Revascularisation in Ischaemic Left Ventricular Systolic Dysfunction: Combined Patient-Level Analysis of the REVIVED-BCIS2 and STICH Trials

Doctor M. Ryan (London, GB)

Presentation thumbnail

Temporary mechanical circulatory support in infarct-related cardiogenic shock - An individual patient data meta-analysis of all randomized trials with 6-month follow-up

Professor H. Thiele (Leipzig, DE)

Access the full session

Session thumbnail

Smaller trials and trial updates on shock, surgery, and other interventions

The Event

Event poster

ESC Congress 2024

2 September 2024 09:33 CET

You may be interested in

Congress Presentation

Prognostic impact of different diagnostic strategies in patients with heart failure with reduced ejection fraction.

Congress Session

Late-breaking science on imaging

Congress Presentation

Differentiating ischaemic versus non-ischaemic aetiology: which imaging technique first?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources